Bristol Myers Squibb has added a familiar face to an ongoing initiative to thank oncologists for the valuable time they return to cancer patients’ lives.
FDA seeks to encourage fewer animal studies with new draft guidance
The FDA unveiled long-awaited draft guidance on how biopharma companies can validate new approaches for toxicology and other early-phase safety studies, potentially reducing the animal


